Quest Diagnostics and New York-Presbyterian agree to laboratory services transaction

Feb. 15, 2023
Goal to serve New York-Presbyterian's providers and patients in the greater New York region and beyond.

Quest Diagnostics, one of the world's leading providers of diagnostic information services, and New York-Presbyterian, one of the nation's largest and most comprehensive academic medical centers, announced a strategic agreement designed to broaden access to quality, innovative laboratory services for the providers and patients of New York-Presbyterian primarily in New York as well as the Tri-State Area and beyond.

The parties expect to complete the transaction in the second quarter of 2023, pending customary regulatory approvals. 

Quest Diagnostics release